NewsMarkets

Business

Moderna to Reveal Phase 3 Cancer Vaccine Data in Collaboration with Merck

The companies are set to release full Phase 3 trial results for their custom cancer treatment this weekend.

2 publishers · 2 articles · first seen 21 Oct 2026 · updated 3h ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

The story so far

2 publishers have covered this in 2 articles since 21 Oct 2026. MarketWatch published first, on 21 October at 15:00 UTC; STAT followed 22h 35m later. The most recent article, from STAT, appeared on 22 October at 13:35 UTC.

Outlets reporting it: MarketWatch, STAT.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. STAT+: What to expect from the Moderna-Merck cancer vaccine data reveal STAT
  2. Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data. MarketWatch

In this story

  • Moderna
  • Merck
Embed this story

Paste this into any web page to show the live odds, with a link back here.